ST
Shailja Tiwari
About Shailja Tiwari
Data last updated:
Shailja Tiwari has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Excipients Zone Limited and Astrazen Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Astrazen Pharmaceuticals Private Limited at ₹4.50 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Mar 2023 | 2020 | ₹4.50 Cr (FY 2025) | Active | |
| Director | 22 May 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shailja Tiwari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shailja Tiwari
Shailja Tiwari has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Excipients Zone Limited and Astrazen Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Astrazen Pharmaceuticals Private Limited at ₹4.50 Cr (FY 2025).
Shailja Tiwari is associated with 2 companies as Director, including Astrazen Pharmaceuticals Private Limited (₹4.50 Cr), Excipients Zone Limited.
Shailja Tiwari has expertise in General Business.
Shailja Tiwari has 5 years in corporate governance.
By reported revenue, the largest current company of Shailja Tiwari is Astrazen Pharmaceuticals Private Limited, with revenue of ₹4.50 Cr (FY 2025).
Shailja Tiwari currently holds positions at 2 companies: Astrazen Pharmaceuticals Private Limited (₹4.50 Cr), Excipients Zone Limited.